PhD in Protein Engineering: Peptides & Ribosome Skipping
Listed on 2026-11-02
-
Research/Development
Research Scientist
The University of Cambridge Department of Pathology and the AstraZeneca Discovery Centre in Cambridge invite applications for a 4-year PhD studentship starting 1 October 2027. The project is jointly supervised by Prof.
Andrew Firth and Dr Giovanni Ciotta, spanning both sites to enable cross-institution collaboration on peptide-bond skipping for protein engineering. The project will explore 2A sequences, ribosome skipping, and their biotechnological applications, with opportunities to learn
This is a strong opportunity to take on the PhD in Protein Engineering: 2A Peptides & Ribosome Skipping role at ASTRAZENECA UK LIMITED.
The following opportunity is for a PhD in Protein Engineering: 2A Peptides & Ribosome Skipping with ASTRAZENECA UK LIMITED.
Our team is growing, and we are hiring a PhD in Protein Engineering: 2A Peptides & Ribosome Skipping in Cambridge, England, United Kingdom.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).